PMC:7321036 / 304-465 JSONTXT

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T9","span":{"begin":121,"end":131},"obj":"SP_7"},{"id":"T10","span":{"begin":145,"end":149},"obj":"CL_6"},{"id":"T78173","span":{"begin":121,"end":131},"obj":"SP_7"},{"id":"T61255","span":{"begin":145,"end":149},"obj":"CL_6"}],"text":" need to develop antiviral therapies. Here we present a quantitative mass spectrometry-based phosphoproteomics survey of SARS-CoV-2 infection in Vero E6 cells, r"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T68056","span":{"begin":153,"end":158},"obj":"Body_part"}],"attributes":[{"id":"A71193","pred":"fma_id","subj":"T68056","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":" need to develop antiviral therapies. Here we present a quantitative mass spectrometry-based phosphoproteomics survey of SARS-CoV-2 infection in Vero E6 cells, r"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T8","span":{"begin":121,"end":129},"obj":"Disease"},{"id":"T9","span":{"begin":132,"end":141},"obj":"Disease"}],"attributes":[{"id":"A8","pred":"mondo_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A9","pred":"mondo_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":" need to develop antiviral therapies. Here we present a quantitative mass spectrometry-based phosphoproteomics survey of SARS-CoV-2 infection in Vero E6 cells, r"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T63961","span":{"begin":54,"end":55},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T6044","span":{"begin":145,"end":158},"obj":"http://purl.obolibrary.org/obo/CLO_0051719"}],"text":" need to develop antiviral therapies. Here we present a quantitative mass spectrometry-based phosphoproteomics survey of SARS-CoV-2 infection in Vero E6 cells, r"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T1","span":{"begin":17,"end":26},"obj":"Chemical"}],"attributes":[{"id":"A1","pred":"chebi_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/CHEBI_22587"}],"text":" need to develop antiviral therapies. Here we present a quantitative mass spectrometry-based phosphoproteomics survey of SARS-CoV-2 infection in Vero E6 cells, r"}

{"project":"LitCovid-PubTator","denotations":[{"id":"26","span":{"begin":121,"end":141},"obj":"Disease"},{"id":"31","span":{"begin":150,"end":152},"obj":"CellLine"}],"attributes":[{"id":"A26","pred":"tao:has_database_id","subj":"26","obj":"MESH:C000657245"},{"id":"A31","pred":"tao:has_database_id","subj":"31","obj":"CVCL:4582"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":" need to develop antiviral therapies. Here we present a quantitative mass spectrometry-based phosphoproteomics survey of SARS-CoV-2 infection in Vero E6 cells, r"}